Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXRN6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,157
Award facts
- Contract value 100% obligated
- $33,156.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $33,156.94 for the supply of Dupixent 300 mg/2 mL syringes on December 22, 2025, with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement valued through December 2026 that serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains extensive relationships with the Defense Logistics Agency for supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a primary pharmaceutical supplier to the Defense Health Agency and other government healthcare systems, the company routinely fulfills delivery orders through open competition, demonstrating its capability to meet federal procurement requirements. This particular order for Dupixent, a specialty biologic medication, exemplifies the company's role in supporting military and federal healthcare needs through the DLA's medical supply chain network.
Quick answers
Who was awarded contract SPE2DR26FXRN6?
SPE2DR26FXRN6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FXRN6 worth?
The government has obligated $33,157 on SPE2DR26FXRN6.
Is contract SPE2DR26FXRN6 an order under another contract?
Yes. SPE2DR26FXRN6 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXRN6 competed?
The extent of competition for SPE2DR26FXRN6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award